CD274 and melanoma: Tseng et al. reported that PAI-1 facilitates programmed death ligand 1(PD-L1) endocytosis of melanoma cells to abrogate the efficacy of anti-PD-L1 antibodies (Abs) in mouse B16F10 melanoma models [44].